Conceptual immune cell in a blood vessel

Cell Therapies and Cancer Vaccines

Immunity that
outlasts cancer.

Two platforms. One ambition.Make immunity last and treatment accessible.

Explore our platforms

Cell Therapies

T-cell and NK-cell delivery.

In vivo delivery

Two distinct platforms

Conceptual CAR spanning an immune-cell membrane

Platform 1

Cell Therapy Toolbox

Delivery. Safety. Persistence.

Explore the toolbox

Different tumor cells with internal and surface antigen diversity

Platform 2

Personalized cancer vaccines

The patient’s tumor becomes the teacher.

Explore PyroCells

Our conviction

Make immunity last.
Make treatment accessible.

01 Broad

Recognize more of the tumor.

Capture the diversity of immune targets.

02 Lasting

Look beyond the first response.

Design for immune function that can endure.

03 Accessible

Rethink the path to the patient.

Make speed, cost, and access part of the ambition.

Team

Built by scientists.
Guided by pioneers.

Archis Bagati, PhD

Founder & Chief Executive Officer

James P. Allison, PhD

Scientific Advisor · 2018 Nobel Laureate

Guenther Koehne, MD, PhD

Clinical Lead Investigator

Minesh Mehta, MD

Clinical Advisor

Padmanee Sharma, MD, PhD

Scientific Advisor

John M. Kirkwood, MD

Clinical Advisor

Richard Kendall, PhD

Scientific Advisor

Michael Amoroso, MBA

Commercial Advisor

Nitin Sood, MS